Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer

NCT00531076 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to toxicity

Conditions

Toxicity

Interventions

BIOLOGICAL: bevacizumab

Sponsor

Amsterdam UMC, location VUmc